Globus Medical (NYSE:GMED) EVP Sells $876,700.00 in Stock

Globus Medical, Inc. (NYSE:GMED) EVP Kelly Huller sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $87.67, for a total value of $876,700.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Kelly Huller also recently made the following trade(s):

• On Tuesday, November 25th, Kelly Huller sold 7,500 shares of Globus Medical stock. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00.

Globus Medical Price Performance

GMED opened at $90.98 on Friday. Globus Medical, Inc. has a 12-month low of $51.79 and a 12-month high of $101.40. The stock has a market capitalization of $12.18 billion, a PE ratio of 29.35, a P/E/G ratio of 1.38 and a beta of 1.06. The firm’s fifty day moving average price is $89.76 and its 200 day moving average price is $74.77.

Institutional Trading of Globus Medical

A number of hedge funds and other institutional investors have recently modified their holdings of GMED. Advisory Services Network LLC acquired a new position in Globus Medical during the third quarter worth about $26,000. EverSource Wealth Advisors LLC boosted its position in shares of Globus Medical by 74.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 462 shares of the medical device company’s stock valued at $27,000 after purchasing an additional 197 shares in the last quarter. Advisors Asset Management Inc. acquired a new position in shares of Globus Medical in the 2nd quarter worth approximately $28,000. SBI Securities Co. Ltd. grew its stake in shares of Globus Medical by 98.2% in the 4th quarter. SBI Securities Co. Ltd. now owns 337 shares of the medical device company’s stock worth $29,000 after purchasing an additional 167 shares during the last quarter. Finally, First Horizon Corp bought a new stake in shares of Globus Medical in the 3rd quarter worth approximately $31,000. Institutional investors own 95.16% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Canaccord Genuity Group lifted their target price on Globus Medical from $105.00 to $112.00 and gave the stock a “buy” rating in a research report on Friday, January 9th. Barclays lifted their price objective on shares of Globus Medical from $106.00 to $114.00 and gave the stock an “overweight” rating in a report on Monday, November 10th. Royal Bank Of Canada increased their target price on shares of Globus Medical from $92.00 to $100.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Piper Sandler reiterated an “overweight” rating and set a $115.00 price target (up from $90.00) on shares of Globus Medical in a research report on Thursday, January 8th. Finally, Wall Street Zen upgraded shares of Globus Medical from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 3rd. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $100.18.

About Globus Medical

Globus Medical, Inc (NYSE:GMED) is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.

In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room.